Erin K. Brenner serves as Executive at Pear Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Erin K. Brenner has executed 4 insider transactions totaling $9.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 20, 2023 involved selling 8,690 shares valued at $9.8K.
Erin K. Brenner currently holds 43,310 shares of Pear Therapeutics, Inc. (PEAR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erin K. Brenner has been a net seller of PEAR stock. They have purchased $0 and sold $9.8K worth of shares.
Erin K. Brenner's most recent insider trade was on Jan 20, 2023, when they sold 8,690 shares at $1.13 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 9, 2022 | PEAR | $15.0K | Option Exercise | 15,000 | $1.00 | Discretionary |
| May 25, 2022 | PEAR | $15.0K | Option Exercise | 15,000 | $1.00 | Discretionary |